ERBB2 and gastric cancer: Furthermore, our work indicates that HER2 membrane availability can be modulated with lovastatin to enhance binding of 89Zr-labeled pertuzumab in HER2-positive gastric cancer cells characterized by a nonpredominant HER2 membrane staining.